Third, because SOX2 confers sensitivity to LSD1 inhibition, we characterized the SOX2 expression pattern using the PAM50 classifier and the integrative clustering of transcriptional data available from the Molecular Taxonomy of Breast Cancer International consortium (METABRIC). This evidence concerns the gene SOX2 and breast cancer.